Author: OurCrowd

[TechCrunch] With Plans of Investing $100M Next Year, Israel’s OurCrowd Forges Its Own Path in Equity Crowdfunding

Sep 26, 2014 |

“OurCrowd, which is run by serial entrepreneur and venture capitalist Jon Medved, has put at least $70 million to work in roughly 50 companies and has plans to invest $100 million more over the next year. One of their companies, ReWalk Robotics, an exoskeleton company that helps disabled people walk again, just IPO-ed a little over week ago and now has a market cap of about $360...

Read More
IPOs: How they work and what they mean for your portfolio

IPOs: How they work and what they mean for your portfolio

Sep 24, 2014 | , ,

In our ‘Teach-In Tuesdays’ webinar series, we explore investing in early-stage Israeli companies, identify and explain influential tech trends, stay up-to-date with the crowdfunding industry, and examine actionable insights from our own experience running OurCrowd’s investment platform. This past Tuesday, OurCrowd hosted a special edition of our ‘Teach-In Tuesdays’ webinar series, in light of the recent ReWalk IPO. ReWalk, the first OurCrowd portfolio company to achieve an exit, recently went public on the NASDAQ (RWLK) prompting a lot of questions from our investor community. Join OurCrowd partner Elan Zivotofsky to learn more about the IPO process and how early stage investors profit from this type of exit. To stay updated on future events and the best news from the Startup Nation, sign up for our newsletter, email us, and follow us on social media. ::::::::::::::::::::::::::::::::: View the FULL program Download/view the presentation To stay updated on future events and the best news from the Startup Nation, sign up for our newsletter, email us, and follow us on social...

Read More

OurCrowd’s portfolio company Consumer Physics featured on CNBC

Sep 17, 2014 | ,

OurCrowd’s portfolio company Consumer Physics, developer of  the world’s first affordable molecular sensor – the SCiO –  that fits in the palm of your hand, has been featured on CNBC’s “Power Pitch.” On the show, Dror Sharon, co-founder of Consumer Physics, had 60 seconds to make his pitch and convince a panel of experts his company has what it takes to become the next big thing. The panel included Clara Sieg, partner with Revolution Ventures, Stephanie Palmeri, principal at SoftTech VC and Mark Siegel, a managing director atMenlo Ventures. CNBC anchor Mandy Drury was the host. “Our mission is to help people better understand the world around them and to encourage our community to help map the physical world,” Sharon told CNBC. “Spectroscopy, the technology, has been used in health care for many, many years and we feel there might be potential killer apps there as well. [We want to] take it to the consumer.” Seeded by OurCrowd and top tier Silicon Valley VC Khosla Ventures, Consumer Physics raised $3,300,000 from OurCrowd investors in its 2nd round of funding in May 2014. View the segment below or read the accompanying article on...

Read More

OurCrowd’s portfolio company Pixie featured in the Wall Street Journal

Sep 15, 2014 | ,

Leading business and finance website, The Wall Street Journal, featured OurCrowd’s portfolio company Pixie. The company is both a technology platform and a consumer product with the goal of keeping the things that matter to you — and to others — in sight. It is the kind of question that pops up with alarming frequency: Where are my keys? Where are my glasses? Where is the cat? A growing number of companies large and small are racing to provide answers via wireless tags that can be attached to household objects (or pet collars) and located with the aid of a smartphone. Amir Bassan-Eskenazi wants to take the concept further. The Israeli entrepreneur co-founded Pixie Technology Inc., which aims to find things with an unusual degree of precision. Pixie raised $1,547,123 from OurCrowd investors in November 2014. Read more on The Wall Street...

Read More

OurCrowd’s portfolio company ReWalk featured on Times of Israel

Sep 15, 2014 | ,

OurCrowd portfolio company ReWalk was featured in the Times of Israel, an English-language news website covering Israel, the region & the Jewish world. FDA approved ReWalk has developed an exoskeleton device that enables paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits. With its successful IPO last week, ReWalk, the company behind the Israeli-developed exoskeleton system designed to help paraplegics walk, is ready to go to market. But that’s not all. The highly praised firm is looking past restoring the use of legs to aiding victims of multiple sclerosis (MS), palsy and strokes. There are good reasons for investors to be as excited about ReWalk as paralyzed individuals are. “We are going to be using the money raised in the IPO to expand our research and production, almost all of which is done in northern Israel,” said [company CEO] Jasinski.   ReWalk raised $1,320,000 from OurCrowd investors in June 2013. Read more on the Times of...

Read More